Stay updated on XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Sign up to get notified when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.

Latest updates to the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page
- ChecktodayChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects an underlying update to the page version behind the study details.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe page footer revision indicator was updated from v3.6.5 to v3.6.6. This reflects a minor page update without changing core content or study details.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page's revision tag has been updated from v3.6.4 to v3.6.5, indicating a minor update to the site's revision history. This change appears to be administrative and does not modify the visible content of the study page.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, signaling a small update to the page's implementation.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page shows a revision update from Revision: v3.6.0 to Revision: v3.6.3, indicating a software update to the study details page.SummaryDifference0.1%

- Check93 days agoChange DetectedRecruitment status now shows 'No longer looking for participants', and new help sections How to Read a Study Record, Common Questions, and How to Join a Study were added. The Intervention / Treatment heading was reformatted to Intervention/Treatment, and the revision note updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.